Filing Details
- Accession Number:
- 0001209191-23-014204
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-01 17:02:09
- Reporting Period:
- 2023-02-27
- Accepted Time:
- 2023-03-01 17:02:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1812025 | Justin Burgess | C/O Dynavax Technologies 2100 Powell Street, Suite 720 Emeryville CA 94608 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-02-27 | 3,166 | $0.00 | 7,287 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-27 | 1,294 | $10.39 | 5,993 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-27 | 1,872 | $10.39 | 4,121 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-02-27 | 6,667 | $0.00 | 10,788 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-27 | 2,717 | $10.39 | 8,071 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-27 | 3,950 | $10.39 | 4,121 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-02-27 | 8,417 | $0.00 | 12,538 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-02-27 | 3,017 | $10.39 | 9,521 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-27 | 5,400 | $10.39 | 4,121 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-02-27 | 4,121 | $10.32 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2023-02-27 | 3,166 | $0.00 | 3,166 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2023-02-27 | 6,667 | $0.00 | 6,667 | $0.00 |
| Commont Stock | Restricted Stock Unit | Disposition | 2023-02-27 | 8,417 | $0.00 | 8,417 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 13,333 | No | 4 | M | Direct | ||
| 8,416 | No | 4 | M | Direct |
Footnotes
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 12, 2020
- The reporting person is reporting the sale of 1,294 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 27, 2023
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022
- The reporting person is reporting the sale of 2,717 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 27, 2023
- Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 3, 2021.
- The reporting person is reporting the sale of 3,017 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 27, 2023
Billionaire Hedge Funds
